Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find
By
McKnight's Staff
Mar 04, 2013
Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who...
Diabetes drugs linked to pancreatitis have a possible cancer connection, FDA says
By
McKnight's Staff
Mar 18, 2013
The Food and Drug Administration is investigating a possible link between commonly prescribed diabetes drugs and pancreatic cancer. The drugs, including Januvia and Byetta, were previously connected with...
New symptoms ID’d that may indicate pancreatic cancer
Nov 18, 2021
Additional symptoms can be used to update QCancer, a risk prediction model that helps physicians identify patients at high risk for cancer
COVID-19 survivors have higher risk for digestive diseases, study finds
By
Kristen Fischer
Jan 17, 2024
People who survived COVID-19 — including some older adults — have a higher risk for digestive diseases, a new study finds.
Diabetes drugs under scrutiny
By
Elizabeth Newman
Apr 01, 2013
Diabetes medications Januvia and Byetta significantly increase the risk of pancreatic inflammation, according to Johns Hopkins University School of Medicine researchers.
Clinical Briefs for Thursday, May 14
By
Alicia Lasek
May 13, 2020
Mental health problems may be new normal for healthcare workers during pandemic … Adults with cancer appear more vulnerable to COVID-19 … Study confirms diabetes 3c diagnosis tied to pancreatic cancer...
Clinical briefs for Wednesday, Aug. 4
By
Alicia Lasek
Aug 04, 2021
Genesis HealthCare requires shots for all: Employees, care partners, onsite vendors must be vaccinated … More than half of U.S. outpatient antibiotics prescriptions not tied to visit or infection …...
Diabetes drugs could be used to treat Alzheimer’s, and vice versa, study finds
By
Phil Brahm
Jun 22, 2016
Drugs used to treat diabetes also could alleviate the symptoms and progression of Alzheimer’s disease, a new study finds.
Effectiveness similar for first-line ACE inhibitors, ARBs in hypertension
Jul 26, 2021
Risks for angioedema, cough, pancreatitis, and GI bleeding significantly lower with ARBs for first-line HTN treatment
Analysis: Medicare beneficiaries less likely to die at top-rated hospitals
By
Haymarket Media
Oct 19, 2007
Medicare beneficiaries on average have a 71% lower chance of dying at one of the nation’s highest-rated hospitals compared with those treated at the lowest-rated hospitals, according to the annual...